Discriminative stimulus effects of the cannabinoid CB₁ receptor antagonist rimonabant in rats

By Järbe Torbjörn   Li Chen   Vadivel Subramanian   Makriyannis Alexandros  

Psychopharmacology, Vol. 198, Iss. 4, 2008-07 ,pp. : 467-478

Springer Publishing Company

Access to resources Recommend Favorite

Discriminative stimulus effects in rats of SR-141716 (rimonabant), a cannabinoid CB₁ receptor antagonist

By Järbe Torbjörn   Harris Michele   Li Chen   Liu Qian   Makriyannis Alexandros  

Psychopharmacology, Vol. 177, Iss. 1-2, 2004-12 ,pp. : 35-45

Springer Publishing Company

Access to resources Recommend Favorite

Effects of the cannabinoid CB₁ receptor antagonist rimonabant on distinct measures of impulsive behavior in rats

By Pattij Tommy   Janssen Mieke   Schepers Inga   González-Cuevas Gustavo   Vries Taco   Schoffelmeer Anton  

Psychopharmacology, Vol. 193, Iss. 1, 2007-07 ,pp. : 85-96

Springer Publishing Company

Access to resources Recommend Favorite

Will the new CB₁ cannabinoid receptor antagonist SR-147778 have advantages over rimonabant?

By Doggrell Sheila A  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 3, 2005-03 ,pp. : 339-342

Informa Healthcare

Access to resources Recommend Favorite

Antiobesity effects of chronic cannabinoid CB 1 receptor antagonist treatment in diet-induced obese mice

By Hildebrandt A.L.   Kelly-Sullivan D.M.   Black S.C.  

European Journal of Pharmacology, Vol. 462, Iss. 1, 2003-02 ,pp. : 125-132

Elsevier

Access to resources Recommend Favorite